newsfilter
← Latest News
GlobeNewswire·

Zogenix to Participate in Two Upcoming Investor Conferences

EMERYVILLE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ:ZGNX), a global biopharmaceutical company developing and commercializing rare disease therapies, today announced that members of its management team will participate in two upcoming